Literature DB >> 11511098

GOA, a novel gene encoding a ring finger B-box coiled-coil protein, is overexpressed in astrocytoma.

D A Vandeputte1, C B Meije, M van Dartel, S Leenstra, H IJlst-Keizers, P K Das, D Troost, D A Bosch, F Baas, T J Hulsebos.   

Abstract

Serial analysis of gene expression (SAGE) was used to identify a gene named GOA (gene overexpressed in astrocytoma), which codes for a novel Ring finger B-box coiled-coil (RBCC) protein. Northern blot hybridization showed overexpression of GOA in 9 of 10 astrocytomas. Except for kidney, in which high expression was found, expression levels in normal tissues were low and comparable to normal brain. Immunohistochemistry demonstrated presence of GOA, with prominent nuclear staining, in astrocytoma tumor cells and astrocytes of fetal brain, but virtual absence in mature astrocytes. Overexpression was not due to amplification, since amplification of GOA was only found in one of 65 astrocytomas. GOA was localized to 17q24-25, a region that is frequently gained or amplified in a number of other tumor types. GOA contains two LXXLL motifs, which are thought to be important for nuclear receptor binding. Our data suggest an important role of GOA in the process of dedifferentiation that is associated with astrocytoma tumorigenesis and possibly with that of other tumor types as well.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11511098     DOI: 10.1006/bbrc.2001.5431

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Genetics of intellectual disability in consanguineous families.

Authors:  Hao Hu; Kimia Kahrizi; Hans-Hilger Ropers; Hossein Najmabadi; Luciana Musante; Zohreh Fattahi; Ralf Herwig; Masoumeh Hosseini; Cornelia Oppitz; Seyedeh Sedigheh Abedini; Vanessa Suckow; Farzaneh Larti; Maryam Beheshtian; Bettina Lipkowitz; Tara Akhtarkhavari; Sepideh Mehvari; Sabine Otto; Marzieh Mohseni; Sanaz Arzhangi; Payman Jamali; Faezeh Mojahedi; Maryam Taghdiri; Elaheh Papari; Mohammad Javad Soltani Banavandi; Saeide Akbari; Seyed Hassan Tonekaboni; Hossein Dehghani; Mohammad Reza Ebrahimpour; Ingrid Bader; Behzad Davarnia; Monika Cohen; Hossein Khodaei; Beate Albrecht; Sarah Azimi; Birgit Zirn; Milad Bastami; Dagmar Wieczorek; Gholamreza Bahrami; Krystyna Keleman; Leila Nouri Vahid; Andreas Tzschach; Jutta Gärtner; Gabriele Gillessen-Kaesbach; Jamileh Rezazadeh Varaghchi; Bernd Timmermann; Fatemeh Pourfatemi; Aria Jankhah; Wei Chen; Pooneh Nikuei; Vera M Kalscheuer; Morteza Oladnabi; Thomas F Wienker
Journal:  Mol Psychiatry       Date:  2018-01-04       Impact factor: 15.992

2.  Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium.

Authors:  Myriam Fornage; Stephanie Debette; Joshua C Bis; Helena Schmidt; M Arfan Ikram; Carole Dufouil; Sigurdur Sigurdsson; Thomas Lumley; Anita L DeStefano; Franz Fazekas; Henri A Vrooman; Dean K Shibata; Pauline Maillard; Alex Zijdenbos; Albert V Smith; Haukur Gudnason; Renske de Boer; Mary Cushman; Bernard Mazoyer; Gerardo Heiss; Meike W Vernooij; Christian Enzinger; Nicole L Glazer; Alexa Beiser; David S Knopman; Margherita Cavalieri; Wiro J Niessen; Tamara B Harris; Katja Petrovic; Oscar L Lopez; Rhoda Au; Jean-Charles Lambert; Albert Hofman; Rebecca F Gottesman; Melissa Garcia; Susan R Heckbert; Larry D Atwood; Diane J Catellier; Andre G Uitterlinden; Qiong Yang; Nicholas L Smith; Thor Aspelund; Jose R Romero; Kenneth Rice; Kent D Taylor; Michael A Nalls; Jerome I Rotter; Richey Sharrett; Cornelia M van Duijn; Philippe Amouyel; Philip A Wolf; Vilmundur Gudnason; Aad van der Lugt; Eric Boerwinkle; Bruce M Psaty; Sudha Seshadri; Christophe Tzourio; Monique M B Breteler; Thomas H Mosley; Reinhold Schmidt; W T Longstreth; Charles DeCarli; Lenore J Launer
Journal:  Ann Neurol       Date:  2011-06       Impact factor: 10.422

3.  TRIM47 activates NF-κB signaling via PKC-ε/PKD3 stabilization and contributes to endocrine therapy resistance in breast cancer.

Authors:  Kotaro Azuma; Kazuhiro Ikeda; Takashi Suzuki; Kenjiro Aogi; Kuniko Horie-Inoue; Satoshi Inoue
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-31       Impact factor: 11.205

4.  Decreased expression of SOX9 indicates a better prognosis and inhibits the growth of glioma cells by inducing cell cycle arrest.

Authors:  Jing Gao; Jia-Yi Zhang; Yu-Hong Li; Fu Ren
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

5.  Gene-mapping study of extremes of cerebral small vessel disease reveals TRIM47 as a strong candidate.

Authors:  Aniket Mishra; Cécile Duplaà; Dina Vojinovic; Hideaki Suzuki; Muralidharan Sargurupremraj; Nuno R Zilhão; Shuo Li; Traci M Bartz; Xueqiu Jian; Wei Zhao; Edith Hofer; Katharina Wittfeld; Sarah E Harris; Sandra van der Auwera-Palitschka; Michelle Luciano; Joshua C Bis; Hieab H H Adams; Claudia L Satizabal; Rebecca F Gottesman; Piyush G Gampawar; Robin Bülow; Stefan Weiss; Miao Yu; Mark E Bastin; Oscar L Lopez; Meike W Vernooij; Alexa S Beiser; Uwe Völker; Tim Kacprowski; Aicha Soumare; Jennifer A Smith; David S Knopman; Zoe Morris; Yicheng Zhu; Jerome I Rotter; Carole Dufouil; Maria Valdés Hernández; Susana Muñoz Maniega; Mark Lathrop; Erik Boerwinkle; Reinhold Schmidt; Masafumi Ihara; Bernard Mazoyer; Qiong Yang; Anne Joutel; Elizabeth Tournier-Lasserve; Lenore J Launer; Ian J Deary; Thomas H Mosley; Philippe Amouyel; Charles S DeCarli; Bruce M Psaty; Christophe Tzourio; Sharon L R Kardia; Hans J Grabe; Alexander Teumer; Cornelia M van Duijn; Helena Schmidt; Joanna M Wardlaw; M Arfan Ikram; Myriam Fornage; Vilmundur Gudnason; Sudha Seshadri; Paul M Matthews; William T Longstreth; Thierry Couffinhal; Stephanie Debette
Journal:  Brain       Date:  2022-06-30       Impact factor: 15.255

Review 6.  Current pathophysiological concepts in cerebral small vessel disease.

Authors:  Fred Rincon; Clinton B Wright
Journal:  Front Aging Neurosci       Date:  2014-03-24       Impact factor: 5.750

7.  TRIM47 is a novel endothelial activation factor that aggravates lipopolysaccharide-induced acute lung injury in mice via K63-linked ubiquitination of TRAF2.

Authors:  Yisong Qian; Ziwei Wang; Hongru Lin; Tianhua Lei; Zhou Zhou; Weilu Huang; Xuehan Wu; Li Zuo; Jie Wu; Yu Liu; Ling-Fang Wang; Xiao-Hui Guan; Ke-Yu Deng; Mingui Fu; Hong-Bo Xin
Journal:  Signal Transduct Target Ther       Date:  2022-05-06

Review 8.  Efp/TRIM25 and Its Related Protein, TRIM47, in Hormone-Dependent Cancers.

Authors:  Kotaro Azuma; Satoshi Inoue
Journal:  Cells       Date:  2022-08-08       Impact factor: 7.666

9.  TRIM47 promotes malignant progression of renal cell carcinoma by degrading P53 through ubiquitination.

Authors:  Jia-Xin Chen; Da Xu; Jian-Wei Cao; Li Zuo; Zhi-Tao Han; Yi-Jun Tian; Chuan-Min Chu; Wang Zhou; Xiu-Wu Pan; Xin-Gang Cui
Journal:  Cancer Cell Int       Date:  2021-02-23       Impact factor: 5.722

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.